Wikipedia -WSS

Wikipedia

author：fashion 2025-10-02 11:09:45 - browse：3

Stock illustration of computer and medication — Adobe

Digital therapeutics company Click Therapeutics announced Wednesday it will acquire the assets of Better Therapeutics, developer of a software-based treatment for diabetes. Click, which did not disclose how much it is paying for the assets, hopes to adapt Better’s tech for use alongside GLP-1 medications.

Better Therapeutics announced in March that it was delisting from the Nasdaq stock exchange and shutting down operations as it sought strategic alternatives. The company had been, since last year, searching for ways to stay afloat as its cash reserves dwindled.

Last, year, Better received Food and Drug Administration clearance for AspyreRx, a prescription app that delivers cognitive behavioral therapy and had been shown to reduce A1c levels in people with type 2 diabetes. Still, the company has been unable to ramp up significant commercial traction. Better also had a pipeline of other products targeting cardiometabolic conditions, and had made early claims about the benefits of AspyreRx in people taking GLP-1s for diabetes management.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Organ aging and disease risk measured by new blood test

hotspot

knowledge

WSS

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Peter Hotez and the public health issue of online harassment

Psychedelics group wrestles with new pharma identity

Despite FDA concern, risk that CAR

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Novavax promises a turnaround & Lilly roils the obesity market

entertainment

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Activists slam private health insurers over coverage restrictions

Organ aging and disease risk measured by new blood test

Duchenne breakthrough therapy leaves behind pioneering families

State Dept. review finds Biden bears some blame for Afghanistan failures

Anesthesiologist group: stop taking Ozempic before surgery

Hepatitis C has a cure — but many Americans still lack access to it

New air purifier tech could be key to improving indoor air quality

Duchenne breakthrough therapy leaves behind pioneering families

Medical leaders decry Supreme Court decision on affirmative action

With clinical trial data readouts, here's how to spot spin

entertainment

Medicare details structure of new drug price negotiation program

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

In Memoriam: Notable people who died in 2023

Supreme Court strikes down use of affirmative action

Organ aging and disease risk measured by new blood test

Wikipedia

hotspot

knowledge

leisure time